Status:
RECRUITING
Influence of Central Versus Peripheral Vestibular Stimulation in Patients With Peripheral Vestibular Disorders
Lead Sponsor:
Cairo University
Conditions:
Peripheral Vestibular Disorders
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Vestibular disorders are disabling conditions that can have a major effect on functioning especially on daily activities and social participation. Latest epidemiological studies estimate that as many ...
Detailed Description
A pilot study has been recruited to calculate sample size and determine rTMs protocol that will be utilized during the study were two protocols has been compared and according to pilot study results c...
Eligibility Criteria
Inclusion
- Definite diagnosis with unilateral peripheral vestibular disorders from audiologist or neurologist.
- The patient's age will be ranged from thirty to sixty years old.
- Patients will experience at least two symptoms of common symptoms of peripheral vestibular disorders.
- Symptoms of vertigo and nystagmus lasting from seconds to one minute.
- Vertigo that arises from changes in head position related to gravity.
- Patients who experienced symptoms for more than three months (chronic patients)
- Patients were selected to be ambulant.
- Patients suffer from balance disturbance with low risk falling (41-56) and moderate risk falling ranges (21-40) according to berg balance scale.
- All patients were medically stable, controlled with medical drugs for at least three months and failed to medical treatment with no other physical, mental or cognitive disorders.
Exclusion
- Benign positional vertigo.
- Central vestibular disorders ( Ms, ataxia, migraine headache, posterior inferior cerebellar artery syndrome "PICA").
- Vertigo that arises from changes in head position not related to gravity; as vertigo of cervical origin or vascular origin ( Vertebro- basilar insufficiency "VBI").
- Previous surgery of the ear.
- Bilateral peripheral vestibular weakness, central vestibular weakness, mixed vestibular weakness, or acute vestibular weakness.
- Unstable health issues (cardiac dysfunction, end stage renal failure, unstable diabetes, uncontrolled hypertension \>190/110…).
- Pacemaker or other implanted electrically sensitive device.
- Significant orthopedic or chronic pain syndrome (e.g any condition that wouldn't permit to completion of any of the tests).
- Major cognitive dysfunction. neurodegenerative disease or major psychiatric condition ( Alzheimer's disease , depression….).
- Chronic use of medications that could influence motor or sensory excitability (e.g AEDs, antipsychotic).
- Alcohol abuse.
- Epilepsy.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04010435
Start Date
February 1 2019
End Date
December 30 2024
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Cairo, Giza Governorate, Egypt, 12613